$CL News

Colgate-Palmolive Stock: Is CL Outperforming the Consumer Defensive Sector?

Colgate-Palmolive (CL) Draws Fresh Valuation Focus, Is The Stock Fully Priced?

Colgate-Palmolive: Don't Ignore This Resilient Dividend King

2 Dividend Kings, 1 Clear Winner: P&G vs. Colgate

Colgate-Palmolive Webcasts Fireside Chat at the Barclays 2026 Global Consumer Staples Conference

Insider Selling: Panagiotis Tsourapas Unloads $920K Of Colgate-Palmolive Stock

Did Colgate-Palmolive’s (CL) Volume-Led Q2 Strength Just Shift Its Investment Narrative?

Household Products Stocks Q2 Teardown: Colgate-Palmolive (NYSE:CL) Vs The Rest

Why Colgate-Palmolive Remains an Overlooked Dividend King

Colgate-Palmolive (CL) Stock Could Trade At A Discount After Its 32% Run

Colgate-Palmolive (CL) Could Be 30% Undervalued Despite A 6% Overvalued Narrative

BJ or CL: Which Is the Better Value Stock Right Now?

5 Revealing Analyst Questions From Colgate-Palmolive’s Q2 Earnings Call

What to Know About Colgate-Palmolive Director John Cahill Selling 4,170 Shares for $389,353

Engaging In Options Activity, Noel Wallace Exercises Options Valued At $6.69M In Colgate-Palmolive

Colgate-Palmolive: The Reasons I Am Still Not A Buyer After The Q2 Results

UBS Maintains Buy on Colgate-Palmolive, Raises Price Target to $109

Colgate-Palmolive Organic Sales Growth to Return to 3%-4% in H2 2026 and 2027, Morgan Stanley Says

TD Cowen Maintains Hold on Colgate-Palmolive, Raises Price Target to $90

JP Morgan Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $103